China to make 100m AstraZeneca Covid-19 vaccine doses by Xmas – Wall Street Journal

AstraZeneca will allow a Chinese company to produce 100 million doses of its experimental Covid-19 vaccine for trial in China by the end of 2020.

AstraZeneca will allow a Chinese company to produce 100 million doses of its experimental Covid-19 vaccine for trial in China by the end of 2020.

This article is exclusive to Biznews Premium. Members please login here. Not yet subscribed? Taste before you eat by signing up here for a half price 30 day trial (card details required).